HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Collagenase Clostridium histolyticum Injection Therapy Improves Health-related Quality of Life in Patients with Dupuytren's Disease.

AbstractOBJECTIVES:
This study was conducted to investigate the changes in clinical and psychosocial outcomes in patients with Dupuytren's disease after initial treatment with collagenase Clostridium histolyticum (CCH) injection.
METHODS:
This study involved 14 patients with Dupuytren's disease who underwent treatment with CCH injection. The range of motion of each phalangeal joint was measured before treatment and at 6 months posttreatment. The following assessments were also carried out pre- and posttreatment: the Geriatric Depression Scale Short - Japanese version (GDS-J) to evaluate depressive status, Hand 10 to assess hand health status, and EuroQol-5-dimension-3-level Japanese version to evaluate health-related quality of life.
RESULTS:
Significant improvements were found in metacarpophalangeal joint extension and proximal interphalangeal joint extension. Significant differences were also found between values before the initiation of CCH injection and those at 6 months posttreatment for the EuroQol index score and the EuroQol Visual Analog Scale (VAS). Significant positive correlations were found between the pre- to posttreatment change in GDS-J scores and for the change in Hand 10 scores. Moreover, a significant negative correlation was found between the change in GDS-J scores and change in EuroQol index scores/EuroQol VAS scores before and at 6 months after CCH injection.
CONCLUSIONS:
For patients with Dupuytren's disease, CCH therapy directly improved the health-related quality of life. The degree of improvement of depressive status was associated with the degree of improvement of hand health status and health-related quality of life.
AuthorsTakuro Kuboi, Tsuyoshi Tajika, Fumitaka Endo, Wataru Goto, Ichiro Nakajima, Satoshi Hasegawa, Daisuke Nakajima, Takafumi Hasokawa, Hirotaka Chikuda
JournalProgress in rehabilitation medicine (Prog Rehabil Med) Vol. 6 Pg. 20210023 ( 2021) ISSN: 2432-1354 [Electronic] Japan
PMID34056142 (Publication Type: Journal Article)
Copyright©2021 The Japanese Association of Rehabilitation Medicine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: